RTA Laboratuvarlari Biyolojik (RTALB) — Strategic Asset Allocation Index
RTA Laboratuvarlari Biyolojik (RTALB) has a Strategic Asset Allocation Index of 7.1% as of June 2023. Strategic assets (PP&E of TL50.64 Million plus long-term investments of TL-) total TL50.64 Million, measured against net assets of TL711.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of RTA Laboratuvarlari Biyolojik to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
RTA Laboratuvarlari Biyolojik Strategic Asset Allocation Index (2010–2022)
This chart shows how RTA Laboratuvarlari Biyolojik's Strategic Asset Allocation Index has evolved across 13 annual periods from 2010 to 2022. As of June 2023, the index stands at 7.1%, representing strategic assets of TL50.64 Million against net assets of TL711.49 Million TRY. For live market cap and overall valuation, see RTALB company net worth.
Annual Strategic Asset Allocation Index for RTA Laboratuvarlari Biyolojik (2010–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for RTA Laboratuvarlari Biyolojik from 2010 to 2022, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See RTALB net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (TRY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 8.5% | TL53.68 Million | TL53.68 Million | TL- | TL632.74 Million | ▼ -5.1 pp |
| 2021 | 13.6% | TL46.75 Million | TL46.75 Million | TL- | TL343.23 Million | ▼ -5.1 pp |
| 2020 | 18.7% | TL31.40 Million | TL31.40 Million | TL- | TL167.81 Million | ▼ -30.9 pp |
| 2019 | 49.6% | TL42.97 Million | TL14.78 Million | TL28.19 Million | TL86.69 Million | ▲ +30.0 pp |
| 2018 | 19.6% | TL11.17 Million | TL11.17 Million | TL- | TL57.06 Million | ▲ +2.1 pp |
| 2017 | 17.5% | TL9.48 Million | TL9.48 Million | TL- | TL54.25 Million | ▼ -5.7 pp |
| 2016 | 23.1% | TL11.62 Million | TL11.62 Million | TL- | TL50.20 Million | ▲ +1.6 pp |
| 2015 | 21.5% | TL10.06 Million | TL10.06 Million | TL- | TL46.74 Million | ▼ -0.4 pp |
| 2014 | 21.9% | TL8.25 Million | TL8.25 Million | TL- | TL37.64 Million | ▼ -16.8 pp |
| 2013 | 38.7% | TL8.06 Million | TL8.06 Million | TL- | TL20.83 Million | ▲ +9.2 pp |
| 2012 | 29.5% | TL3.24 Million | TL3.24 Million | TL- | TL10.99 Million | ▲ +11.4 pp |
| 2011 | 18.0% | TL1.84 Million | TL1.84 Million | TL- | TL10.19 Million | ▼ -1.1 pp |
| 2010 | 19.1% | TL2.19 Million | TL2.19 Million | TL- | TL11.46 Million | — |